PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
26-Oct-2022 RELIEF THERAPEUTICS Holding SA and NRx Pharmaceuticals, Inc. extend their stay of pending litigation to provide additional time for the parties to finalize their settlement Relief Therapeutics Holding SA
25-Oct-2022 MEDICLIN reaches agreement regarding early renewal of lease agreements for 20 clinic locations and settlement of lease dispute with (former) shareholders MediClin AG
25-Oct-2022 OxSonics Presents Preclinical Data Demonstrating SonoTran® Enhanced the Delivery and Efficacy of an Oncolytic Virus in a Murine Bladder Cancel Model B3C newswire
25-Oct-2022 BRAIN Biotech and Bonumose collaborate on enzymes for the production of rare monosaccharides BRAIN Biotech AG
25-Oct-2022 CHEPLAPHARM receives growth capital of EUR 550 million from two leading global investors Cheplapharm AG
25-Oct-2022 Q3/2022: Solid third quarter with slight sales growth in persistently volatile market environment; US business back on track with significant +45 % sales increase aap Implantate AG
25-Oct-2022 Evotec enters partnership with Hannover Medical School to create molecular patient database in autoimmune diseases Evotec SE
25-Oct-2022 Relief Therapeutics Files Amendment No. 2 to its Form F-6 Registration Statement with the U.S. Securities and Exchange Commission Relief Therapeutics Holding SA
24-Oct-2022 FIRST LICENSED MELATONIN FOR SLEEP DISORDERS IN CHILDREN AND ADOLESCENTS WITH ADHD LAUNCHES IN UK AGB-Pharma
24-Oct-2022 Sartorius Enters Research Partnership with The BASE Facility at the University of Queensland B3C newswire
21-Oct-2022 Weekly Pharma & Life Science News Round-Up: 17th-21st October PharmiWeb.Jobs
21-Oct-2022 Olympus Announces Leadership Succession Plan Olympus
21-Oct-2022 MorphoSys Reports Preliminary Q3 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022 MorphoSys AG
21-Oct-2022 Ad hoc: MorphoSys AG Reports Preliminary Q3 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022 MorphoSys AG
21-Oct-2022 Serum TDP-43 levels can help to identify common neuropathological changes associated with frontotemporal dementia University of Eastern Finland
21-Oct-2022 Elekta Unity’s motion management capabilities herald a new era in precision radiation therapy Elekta
21-Oct-2022 AlzeCure presents new data with its preventive treatment Alzstatin at the Alzheimer conference CTAD AlzeCure
21-Oct-2022 Alderley Park sees a brand new cutting-edge cell and gene therapy manufacturing facility thanks to Charles River Laboratories Charles River Laboratories International
21-Oct-2022 OSE Immunotherapeutics Updates on Tedopi®, a Cancer Vaccine as Potential New Standard of Care in Non-Small Cell Lung Cancer After Failure to Immunotherapies OSE Immunotherapeutics
21-Oct-2022 Cegedim acquires French medical data expert Clinityx, strengthening its position in Real-World-Data Cegedim